Literature DB >> 8506886

Influence of labetalol on cocaine-induced coronary vasoconstriction in humans.

J D Boehrer1, D J Moliterno, J E Willard, L D Hillis, R A Lange.   

Abstract

PURPOSE: Although labetalol is sometimes given to patients with cocaine-associated chest pain, its influence on cocaine-induced coronary vasoconstriction is unknown. PATIENTS AND METHODS: In 15 patients (7 men, 8 women, aged 40 to 79 years) undergoing catheterization for chest pain, heart rate, mean arterial pressure, and coronary arterial area (by computer-assisted quantitative angiography) were measured (1) at baseline, (2) 15 minutes after intranasal cocaine, 2 mg/kg, then (3) 5 minutes after intravenous saline (n = 6) or labetalol, 0.25 mg/kg (n = 9).
RESULTS: Of 40 coronary arterial segments analyzed, cocaine induced a 13% +/- 10% (mean +/- standard deviation) decrease in coronary arterial area in 32. Subsequently, no variable changed after saline administration. Although labetalol reduced mean arterial pressure (117 +/- 14 mm Hg after cocaine, 110 +/- 11 mm Hg after labetalol; p < 0.05), it induced no change in the coronary arterial area (3.47 +/- 1.37 mm2 after cocaine, 3.37 +/- 1.32 mm2 after labetalol; p = NS).
CONCLUSION: Labetalol reverses the cocaine-induced rise in mean arterial pressure, but does not alleviate cocaine-induced coronary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506886     DOI: 10.1016/0002-9343(93)90212-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Authors:  Cm Hysek; Y Schmid; A Rickli; L D Simmler; M Donzelli; E Grouzmann; M E Liechti
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

Review 3.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 4.  Best evidence topic report. Beta-Blockers in cocaine induced acute coronary syndrome.

Authors:  Ayan Sen; Tim Fairbairn; Freya Levy
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

5.  Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy.

Authors:  L Öcal; H Çakir; M Tellice; S İzci; E Alizade; A M Esen
Journal:  Herz       Date:  2013-11-01       Impact factor: 1.443

6.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.

Authors:  Cédric M Hysek; Yasmin Schmid; Anna Rickli; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

7.  Carvedilol Among Patients With Heart Failure With a Cocaine-Use Disorder.

Authors:  Dahlia Banerji; Raza M Alvi; Maryam Afshar; Noor Tariq; Adam Rokicki; Connor P Mulligan; Lili Zhang; Malek O Hassan; Magid Awadalla; John D Groarke; Tomas G Neilan
Journal:  JACC Heart Fail       Date:  2019-09       Impact factor: 12.035

8.  Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease.

Authors:  Mina M Benjamin; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

Review 9.  Cocaine and the heart.

Authors:  M Egred; G K Davis
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

10.  Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction.

Authors:  Fareed N Fareed; Gar Chan; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.